Join Now

Category Archives: BioUtah News

Genomics 101 by Intermountain Precision Genomics

By Natalie Themm | Published August 19, 2021

In a recent article published by Utah Business Magazine, Dr. Lincoln Nadauld, Chief of Precision Health at Intermountain Healthcare, provides an explanation of the genomic world and how precision medicine will be evolving in the future. Intermountain Precision Genomics, a BioUtah member, is located in St. George, Utah and is a world leader in genomics.

| Tagged , | Leave a comment

Recursion Reports Second Quarter 2021 Financials and Provides Business Updates

By Natalie Themm | Published August 19, 2021

Recursion, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, today reported financial results and business updates for its second quarter ending June 30, 2021.

| Tagged | Leave a comment

CenExel Clinical Research Acquires Advanced Memory Research Institute

By Natalie Themm | Published August 19, 2021

CenExel announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”), the largest Alzheimer’s Disease clinical research site in the Northeast. CenExel AMRI conducts Phase I through Phase IV studies, primarily in Alzheimer’s Disease, Memory Loss, and Dementia research.

| Tagged | Leave a comment

U.S. SKI & SNOWBOARD CHOOSES R-ZERO AS ITS BIOSAFETY PARTNER TO PROTECT ATHLETES AND STAFF

By Natalie Themm | Published August 19, 2021

U.S. Ski & Snowboard joins the growing list of professional sports organizations, including NBA and NFL teams, using R-Zero’s tech to reduce health risks from COVID-19 and other airborne and surface pathogens

| Tagged | Leave a comment

Representative Moore Tours Utah Companies – BD, Edwards Lifesciences and Stryker

By Denise Bell | Published August 12, 2021

BioHive on Wednesday was front and center as U.S. Representative Blake Moore (R-UT-1) toured Edwards Lifesciences, BD and Stryker – all leading medical device manufacturers in Utah that provide thousands of good-paying, stable jobs. During the visits, Moore was able to see first-hand the work that these companies do to innovate and produce life-changing technologies.  “We […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results

By Natalie Themm | Published August 12, 2021

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the second quarter ended June 30, 2021.

| Leave a comment

PolarityTE Reports Second Quarter Financial Results

By Natalie Themm | Published August 12, 2021

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the second quarter ended June 30, 2021.

| Leave a comment

Cytiva acquires Intermountain Life Sciences

By Natalie Themm | Published August 12, 2021

Global life sciences leader Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output.

| Leave a comment

Jackson Hospital Continues to Lead by Adding New Non-Invasive Ventilation (NIV) Products; ReddyPort™ Elbow and NIV Maintenance for Oral Care

By admin | Published August 5, 2021

ReddyPort, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market

| Leave a comment

ELITechGroup received the CE mark for Saliva on SARS-CoV-2 ELITe MGB® Kit

By admin | Published August 5, 2021

ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit.

| Leave a comment

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021

By Natalie Themm | Published August 5, 2021

The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company’s stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. 

Also posted in Press Releases | | Tagged , | Leave a comment

CenExel Clinical Research Acquires ForCare Clinical Research

By Natalie Themm | Published August 5, 2021

CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience. CenExel FCR conducts Phase I through Phase IV studies in both chronic and acute conditions, primarily in Dermatology

Also posted in Press Releases | | Tagged , | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members